Skip to main content
CBUS
NASDAQ Industrial Applications And Services

Cibus Extends Cash Runway to Q1 2027, Beats Q1 Revenue Estimates, and Narrows Net Loss

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.41
Mkt Cap
$107.647M
52W Low
$1.09
52W High
$4.191
52W Position info
29% above low
Off High info
66% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

CBUS sits 29% above its 52-week low of $1.09 on light trading volume (0.4× avg).

Summary

Cibus, Inc. reported Q1 2026 financial results, extending its cash runway into late Q1 2027, surpassing revenue estimates, and significantly narrowing its net loss due to cost reduction initiatives and recent capital raises.


Key Events · Earnings and Guidance · CBUS

  • Cash Runway Extended

    The company now expects existing cash and cash equivalents of $30.3 million (as of March 31, 2026) to fund operations into late Q1 2027, a significant improvement from the late Q3 2026 projection in the prior 10-K.

  • Q1 Revenue Beat Estimates

    Cibus reported Q1 2026 revenue of $1.68 million, exceeding analyst estimates of $1.62 million and up from $1.03 million in the year-ago period.

  • Net Loss Significantly Narrowed

    The net loss for Q1 2026 was $21.2 million, a substantial reduction from $49.4 million in Q1 2025, driven by cost reduction initiatives and the absence of goodwill impairment this quarter.

  • Operational Efficiency and Capital Raises

    The company is on track to deliver annual net cash usage of $30 million or less in 2026, supported by reduced R&D and SG&A expenses, and approximately $33 million in net proceeds from equity sales during the quarter.


Analysis · CBUS · Industrial Applications And Services

This filing provides a critical update on Cibus' financial health, significantly extending its cash runway from late Q3 2026 (as reported in the March 17, 2026 10-K) to late Q1 2027. This extension, driven by recent capital raises and substantial cost reductions, directly addresses the prior going concern warning and provides the company with more time to achieve commercial milestones. The Q1 revenue beat and narrowed net loss further indicate improved operational performance.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CBUS was trading at $1.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $107.6M. The 52-week trading range was $1.09 to $4.19. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CBUS - Latest Insights

CBUS
Nov 12, 2026, 4:34 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.15 info
Change: +$0.070 (+6%) info
Market Cap: $86.365M info
CBUS
Nov 12, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.08
Real-time Price: $1.15 info
Change: +$0.070 (+6%) info
Market Cap: $86.365M info
CBUS
Aug 13, 2026, 4:32 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.62
Real-time Price: $1.15 info
Change: -$0.4663 (-29%) info
Market Cap: $86.365M info
CBUS
Aug 13, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.68
Real-time Price: $1.15 info
Change: -$0.530 (-32%) info
Market Cap: $86.365M info
CBUS
Jun 17, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $1.15 info
Change: -$0.170 (-13%) info
Market Cap: $86.365M info